Dissemination of the Clinical Practice Guideline entitled Complementary and

描述(由申请人提供)：循证临床实践指南是针对特定临床问题或问题提供优化患者护理建议的声明。然而，仅仅阅读指南的行为很少导致建议的执行，需要积极传播。美国神经病学学会(AAN)有一个正式的指南制定和传播给医生和患者的过程。社交媒体(Face Book、Twitter等)的角色以及更新的传播方式(播客、网络研讨会等)在指南中，传播还没有被研究过。AAN目前正在制定一份基于证据的指南，题为“补充和替代医学(CAM)在多发性硬化症(MS)中的应用”，以就多发性硬化症(MS)中补充和替代医学(CAM)的安全性和有效性提出建议。这个话题非常重要，因为多发性硬化症患者经常使用CAM，他们很少与医生讨论他们使用CAM的情况。目标：具体目标1：为题为“MS中的CAM”的指南制定一种新的、创新的传播战略，结合传统(目前使用的方法)和较新的方法。具体目标2：通过过程和结果措施衡量传播战略的有效性。具体目标3：比较不同传播方法在不同目标受众中的效果，以便评价最适合每个受众的传播方法。这项建议涉及AHRQ的两个研究组合：患者安全和创新/新出现的问题，以及AHRQ优先考虑的有特殊卫生保健需求的个人群体。这与PCORI的研究问题是一致的：评估卫生提供系统干预措施的益处，并解决实施和传播的个体差异和障碍。方法：传播计划将包括传播前调查，以确定问题并确定受众、关怀方面的差距、实施障碍和传播机会。传播战略将利用传统和非传统的创新方法。在分发了指南后，将使用过程测量来评估该策略的有效性：该指南覆盖了多少患者和医生？和结果指标：实践模式的改变：即，医生是否开始定期询问患者有关CAM使用的情况？患者是否改变了CAM的使用？最后，将对每种传播方法和每个目标受众的过程和结果措施进行评估。结论：这项研究的结果通过确定有效的传播方法来高效地和有效地利用资源，总体上对基于证据的指南的未来传播工作具有强烈的影响。从该项目中吸取的经验教训将影响指导方针传播方法总体模式的制定。

DESCRIPTION (provided by applicant): Evidence-based clinical practice guidelines are statements that provide recommendations to optimize patient care for a specific clinical problem or question. However, the mere act of reading a guideline rarely leads to implementation of recommendations, and active dissemination is required. The American Academy of Neurology (AAN) has a formal process of guideline development and dissemination to physicians and patients. The role of social media (face book, twitter, etc.) and newer methods of dissemination (podcasts, webinars etc.) in guideline dissemination has not been studied. The AAN is currently developing an evidence- based guideline entitled "Complementary and Alternative Medicine (CAM) in multiple sclerosis (MS)" to make recommendations regarding the safety and efficacy of CAM in MS. This topic is very important because CAM is frequently used by MS patients, who seldom discuss their use of CAM with their physicians. Objectives: Specific Aim 1: To institute a new, innovative dissemination strategy combining traditional (presently used methods) and newer methods for the guideline entitled "CAM in MS". Specific Aim 2: To measure the effectiveness of the dissemination strategy by process and outcome measures. Specific Aim 3: To compare the effectiveness of different methods of dissemination in different target audiences in order to evaluate the best methods of dissemination for each audience. This proposal addresses two AHRQ portfolios of research: patient safety and innovations/emerging issues, and the AHRQ priority population of individuals with special health care needs. It is in keeping with PCORI's research questions: to assess the benefits of health delivery system interventions and to address individual differences and barriers to implementation and dissemination. Methods: The dissemination plan will include a pre- dissemination survey to define the problem and identify the audience, gaps in care, implementation barriers, and dissemination opportunities. The dissemination strategy will utilize both traditional and non-traditional, innovative methods. Having disseminated the guideline, the effectiveness of the strategy will be evaluated using process measures: how many patients and physicians did the guideline reach? and outcome measures: change in practice patterns: i.e., did physicians start asking patients regularly about CAM use? Did patients make changes in CAM use? Finally, the process and outcome measures will be evaluated for each dissemination method, and for each target audience. Conclusion: The results of this study have strong implications for future dissemination efforts for evidence based guidelines in general by identifying effective dissemination methods that utilize resources efficiently and effectively. Lessons learned from this project will influenc the development of models for guideline dissemination methods in general.